These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 2889354)

  • 21. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
    De Natale G; De Natale F; Marino A
    Clin Ter; 1989 Apr; 129(1):3-16. PubMed ID: 2567647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ranitidine v. cimetidine in peptic ulcer.
    Drug Ther Bull; 1982 Jul; 20(15):57-9. PubMed ID: 6128213
    [No Abstract]   [Full Text] [Related]  

  • 23. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease].
    Simon B; Müller P; Dammann HG
    Wien Med Wochenschr; 1982 May; 132(10):223-8. PubMed ID: 6126962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overview of the safety profile of the H2-receptor antagonists.
    Hansten PD
    DICP; 1990 Nov; 24(11 Suppl):S38-41. PubMed ID: 1980183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The status of H2-blocker therapy today].
    Rameis H
    Wien Med Wochenschr; 1992; 142(18):398-405. PubMed ID: 1362029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug therapy of peptic ulcer disease.
    Peppercorn MA
    Compr Ther; 1983 Nov; 9(11):47-52. PubMed ID: 6139199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The H2-antagonist therapy withdrawal syndrome: the possible role of hyperprolactinemia].
    Rampello L; Nicoletti G
    Medicina (Firenze); 1990; 10(3):294-6. PubMed ID: 1981922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety issues relating to long-term treatment with histamine H2-receptor antagonists.
    Sabesin SM
    Aliment Pharmacol Ther; 1993; 7 Suppl 2():35-40. PubMed ID: 8103374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [H2 antagonists as inhibitors of cytochrome P-450 in rat liver: in vitro and in vivo effects].
    Carrasco M; Gaule C; Vega P; del Villar E
    Rev Med Chil; 1992 May; 120(5):539-44. PubMed ID: 1364175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical importance of the new H2-antagonists.
    Walt RP
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():97-9. PubMed ID: 2566730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Possibly ranitidine-induced autoimmune hepatitis].
    Luparini RL; Rotundo A; Mattace R; Marigliano V
    Ann Ital Med Int; 2000; 15(3):214-7. PubMed ID: 11059062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatoprotective, antinociceptive and antioxidant activities of cimetidine, ranitidine and famotidine as histamine H2 receptor antagonists.
    Ahmadi A; Ebrahimzadeh MA; Ahmad-Ashrafi S; Karami M; Mahdavi MR; Saravi SS
    Fundam Clin Pharmacol; 2011 Feb; 25(1):72-9. PubMed ID: 20070855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative evaluation of cimetidine and ranitidine.
    Zimmerman TW; Schenker S
    Ration Drug Ther; 1985 Apr; 19(4):1-7. PubMed ID: 2932770
    [No Abstract]   [Full Text] [Related]  

  • 34. [What is important in treating elderly with H2 receptor antagonists].
    Kurosawa S
    Nihon Rinsho; 2002 Aug; 60(8):1613-7. PubMed ID: 12187760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recent aspects of drug interactions with the H2 antagonists cimetidine and ranitidine. A review of the literature].
    Kirch W; Ohnhaus EE
    Med Klin (Munich); 1987 May; 82(11):400-4. PubMed ID: 3600542
    [No Abstract]   [Full Text] [Related]  

  • 36. [Medical therapy of peptic ulcer: problems and prospects].
    Trabucchi E; Foschi D; Belloli P; Montorsi F; Marchetti V; Mariscotti C; Diamantini S
    Minerva Dietol Gastroenterol; 1989; 35(1):1-6. PubMed ID: 2566959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The risk of acute liver injury associated with cimetidine and other acid-suppressing anti-ulcer drugs.
    García Rodríguez LA; Wallander MA; Stricker BH
    Br J Clin Pharmacol; 1997 Feb; 43(2):183-8. PubMed ID: 9131951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical review of histamine2 receptor antagonists.
    Lipsy RJ; Fennerty B; Fagan TC
    Arch Intern Med; 1990 Apr; 150(4):745-51. PubMed ID: 1970232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the H2 histamine receptor antagonist on oxygen metabolism in some morphotic blood elements in patients with ulcer disease.
    Kedziora-Kornatowska K; Tkaczewski W; Blaszczyk J; Buczynski A; Chojnacki J; Kedziora J
    Hepatogastroenterology; 1998; 45(19):276-80. PubMed ID: 9496526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hemolytic anemia and thrombocytopenia induced by cimetidine: recurrence with ranitidine administration].
    Takimoto R; Mogi Y; Kura T; Niitsu Y
    Rinsho Ketsueki; 1997 Feb; 38(2):124-8. PubMed ID: 9059066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.